Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study (Q44623048)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2013
edit
Language Label Description Also known as
English
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study
scientific article published in September 2013

    Statements

    Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study (English)
    Alberto J Spindler
    Frédéric A Houssiau

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit